See the Presentations of the 2016 Chile Sessions

Jornadas Chile 2016 | Puerto VarasWe thank all the speakers of the Chile 2016 Sessions who shared their presentations to contribute to our mission of promoting the dissemination of information from research and clinical practice in Interventional Cardiology.

You can read and/or download them below

 

  • Lluberas, Ricardo. “Role of pharmacovasive therapy in the treatment of IAMcEST. Implications for Latin America”.

  (spanish version)

 

  • Mayol, Jorge. “Angioplasty in acute myocardial infarction with ST elevation with multivessel disease: is only the culprit enough?”.

  (spanish version)

 

  • More Dale, Jorge. “Platelet anti-aggregation in acute coronary syndrome in 2016”.

  (spanish version)

 

  • Dussaillant Nielsen, Gastón. “Antithrombotic therapy in atrial fibrillation and stents: balancing the risk of stroke vs. the risk of bleeding”.

  (spanish version)

 

  • Martínez Sepúlveda, Alejandro. “Update on TAVI: 2016 results and new indications”.

  (spanish version)

 

  • Echeverri, Darío. “Decision making in multivessel disease: keys to select the appropriate revascularization technique”.

(spanish version)

 

  • Echeverri, Darío. “Should we be alerted to the long-term durability and thrombogenicity of percutaneous prostheses?”.

(spanish version)

 

  • A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. “Intracoronary Imaging For Complex PCI”.

(spanish version)

 

  • Berrocal, Daniel. “The asymptomatic patient with severe aortic stenosis: is there a role of early valve intervention?”.

(spanish version)

 

  • A Pichard, L Satler, Ron Waksman, I Ben-Dor, P Corso, C Shults, N Bernardo, E Woo, G Weigold, G Weissman, A Ertel, T. Weddington, S Boyce, A Bafi, P Okubagzi. “TAVR Devices for Special Anatomies”.

(spanish version)

 

  • Simpferdorfer, Conrad. “Revascularization in the diabetic patient”.

(spanish version)

 

  • A Pichard, Ron Waksman. “Magmaris Stent (Biotronik)”.

(spanish version)

 

  • Castellano, José. “The close relationship between adherence to treatment and CV results”.  

(spanish version)

 

  • Alfonso, Fernando. “Treatment of restenosis of the pharmacoactive stent”.

(spanish version)

 

  • Mangione, José. “Duration of post-implant medicated stent antiplatelet therapy: 6, 12 months or more?”.

(spanish version)

 

  • Alfonso, Fernando. “The debate between the IVUS and the OCT in coronary angioplasty”.

(spanish version)

 

  • Pincetti J., Christian. “Is there a light at the end of the tunnel for renal denervation?”.

(spanish version)

 

  • Halac, Marcelo. “Selection of the best time to revascularize when the decision is to implant a percutaneous valve”.

(spanish version)

 

  • Leiva Pons, José Luis. “Bioabsorbable platforms in the treatment of coronary heart disease”.

(spanish version)

 

  • Stockins, Benjamin. “Some considerations on interventional cardiology in Chile”.

(spanish version)

 

  • Halac, Marcelo. “SOLACIrio SOLACIrio Program”.

(spanish version)

 

  • Maluenda G, Assef V, Baeza C, Caorsi C, Sepulveda E, Sepulveda E, Alfaro M, Molina JL. “Successful Valve-in-Valve in advanced pregnancy for degenerated and ruptured bioprosthetic aortic valve”.

(spanish version)

 

  • Arrieta, Raúl. “Solidary Case, Chile Session- Chile Case”.

(spanish version)

 

  • Iñiguez, Andrés. “ICP: Antiplatelet / anticoagulation in patients with Risk of Bleeding”.

(spanish version)

 

  • Iñiguez, Andrés. “Role of imaging and functional evaluation in complex coronary patients”.  

(spanish version)

 

  • Echeverri, Darío. “Percutaneous treatment of mitral regurgitation with Mitraclip: the evidence and how to develop a program”.

(spanish version)

 

  • Alfonso, Fernando. “What can the intracoronary OCT provide us with?”.

(spanish version)

 

  • Alfonso, Fernando. “When the OCT changes the diagnostic and therapeutic strategy in acute coronary syndrome”.

(spanish version)

 

  • Dussaillant, Gastón. “Definition and importance of the patient at high risk of post angioplasty bleeding”.  

(spanish version)

 

  • Londero, Hugo. “Rational confrontation of the patient with Severe Aortic Stenosis and Left Ventricular Dysfunction”.  

(spanish version)

 

  • Leiva Pons, José Luis. “IMEST Prehospital Care Networks: Mexico Infarction Code”.  

(spanish version)

 

  • Mangione, José. “One Case – One Teaching”.

(spanish version)

  • Sepúlveda, Pablo. “Primary angioplasty in Chile”.

(spanish version)

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....